Tailored Patient-centric Solutions to Maximize Clinical Trial Recruitment & Retention

Ensuring diversity and access to special patient populations for clinical trial participation is essential as people of different ages, races, ethnicities, genders, socioeconomic backgrounds, geographic locations, and disease characteristics may experience treatments differently.

Employing a comprehensive, multi-pronged strategy requires:

• Strategic site selection and patient access expertise: Allucent Site Intelligence carefully identifies and selects sites with proven access to underrepresented, underserved, and hard-to-reach patient populations and has expertise in engaging these patients throughout the clinical trial journey.
• Tailored diversity and inclusion strategies: Clinical trial-specific diversity plans are aligned with individual site strategies, recruitment goals, and therapeutic area requirements, ensuring we meet targets reliably and predictably.
• Patient-centered education and engagement: Our in-house patient education and information capabilities ensure effective communication using language and imagery that resonates with the patient, reduces participation barriers, and fosters trust.
• Reducing participation barriers: Travel, logistics, and concierge services help limit out-of-pocket expenses for participants, enabling broader access and increasing trial diversity.

Educated patients are more likely to stay engaged and less likely to drop out if they have realistic expectations of processes and outcomes.

Allucent’s Patient Engagement groups in-house graphics capabilities enable agile development of clinical trial-specific materials designed to engage patients, their families, participating sites, referring physicians, and other stakeholders in the patients’ healthcare community.

We utilize our Patient Voice offering to enhance our understanding of the patient’s burden and study experience. This ensures that our messaging and imagery resonate fully with the target patient population.

We can swiftly engage with “patient-like” individuals from the trial population to explore all aspects of their disease experience and where they seek healthcare information, supporting the creation of customized, patient-centric engagement strategies.

Our services are developed quickly and cost-effectively to meet the needs of our sponsors.